Abstract
Medicaid beneficiaries with schizophrenia and bipolar disorder require a range of services and supports. This descriptive study used 2007 Medicaid claims data from 21 states and the District of Columbia to examine the extent to which this population received guideline-concordant medications, medication monitoring, outpatient mental health care, and preventive physical health care. More than 80 % of beneficiaries in each state filled at least one prescription for a guideline-concordant medication during the year but, on average, only 57 % of those with schizophrenia and 45 % of those with bipolar disorder maintained a continuous supply of medications. Roughly 25 % did not have an outpatient mental health visit during the year (excluding case management and some other services); in some states more than half did not have such a visit. Only 11 % of beneficiaries received a physical health examination or health behavior counseling when claims codes were used to identify these services rather than all primary care physician visits. Less than 5 % of beneficiaries maintained their supply of medications, received medication monitoring and had an outpatient mental health visit, physical health examination or received health behavior counseling during the year. Although these rates of service utilization are likely conservative and the data predate recent efforts to integrate care, the findings underscore the need for quality improvement efforts targeted to this population and may provide a baseline for monitoring progress.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartels, S. J., Clark, R. E., Peacock, W. J., Dums, A. R., & Pratt, S. I. (2003). Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. American Journal of Geriatric Psychiatry, 11(6), 648–657.
Brown, J., Barrett A., Ireys H., Caffery, E., & Hourihan, K. (2012). Evidence-based practices for medicaid beneficiaries with schizophrenia and bipolar disorder. Retrieved from http://aspe.hhs.gov/daltcp/reports/2012/ebpsbd.shtml.
Busch, A. B., Lehman, A. F., Goldman, H., & Frank, R. G. (2009). Changes over time and disparities in schizophrenia treatment quality. Medical Care, 47(2), 199–207.
Busch, A. B., Ling, D., Goldman, R. G., & Greenfield, S. F. (2007). Changes in the quality of care for bipolar I disorder during the 1990s. Psychiatric Services, 58(1), 27–33.
Durden, E., Bagalman, E., Muser, E., Choi, J. C., Crivera, C., Dirani, R., et al. (2010). Characteristics, healthcare utilization and costs of bipolar disorder type I patients with and without frequent psychiatric intervention in a medicaid population. Journal of Medical Economics, 13, 698–704.
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004). Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. The American Journal of Psychiatry, 161, 692–699.
Greenberg, L. (2012). Best practices compendium for serious mental illness. (Report for Medicaid Health Plans of American Center for Best Practices). Retrived from http://www.mhpa.org/_upload/SMICompendiumFINALweb_744522.pdf.
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H., et al. (2010). The World federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2010 on the treatment of acute bipolar depression. The World Journal of Biological Psychiatry, 11, 81–109.
Guo, J. J., Heck, P. E., Li, H., & Patel, N. C. (2007). Treatment costs related to bipolar disorder and comorbid conditions among medicaid patients with bipolar disorder. Psychaitric Services, 58(8), 1073–1078.
Hamblin, A., Verdier, J., & Au, M. (2011). State options for integrating physical and behavioral health care (ICRC Technical Assistance Brief). Retrieved from http://www.integratedcareresourcecenter.com/pdfs/ICrC_bh_briefing_document_1006.pdf.
Hassan, M., & Lage, M. J. (2009). Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. American Journal of Health-System Pharmacy, 66, 358–365.
Kilbourne, A. M., Post, E. P., Bauer, M. S., Zeber, J. E., Copeland, L. A., Good, C. B., et al. (2007). Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. Journal of Affective Disorders, 102, 145–151.
Kim, J. Y., Higgins, T. C., Esposito, D., Gerolamo, A. M., & Flick, M. (2012). SMI innovations project in Pennsylvania: Final evaluation report. Report prepared for the Center for Health Care Strategies. Retrieved from http://www.chcs.org/usr_doc/Mathematica-RCP-FinalReport-2012.pdf.
Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., & Schizophrenia Patient Outcomes Research Team. (2010). The Schizophrenia patient outcomes research team (PORT): Updated treatment recommendations 2009. Schizophrenia Bulletin, 36, 94–103.
Lang, K., Meyers, J. L., Korn, J. R., Lee, S., Sikirica, M., Crivera, C., et al. (2010). Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatric Services, 61(12), 1239–1247.
Li, J., McCombs, J. S., & Stimmel, G. L. (2002). Cost of treating bipolar disorder in the California medicaid (Medi-Cal) program. Journal of Affective Disorders, 71, 131–139.
Marcus, S. C., & Olfson, M. (2008). Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophrenia Bulletin, 34, 173–180.
Marcus, S. C., Olfson, M., Pincus, H. A., Zarin, D., & Kupfer, D. J. (1999). Therapeutic drug monitoring of mood stabilizers in medicaid patients with bipolar disorder. Psychiatric Services, 156, 1014–1018.
Mehrotra, A., Zaslavsky, A. M., & Ayanian, J. Z. (2007). Preventive health examinations and preventive gynecological examinations in the United States. Archives of Internal Medicine, 167(17), 1876–1883.
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M., Petukhova, M., & Kessler, R. C. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National comorbidity survey replication. Archives of General Psychiatry, 64(5), 543–552.
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & DeHert, M. (2012). Guidleine concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices. Psychological Medicine, 42, 125–147.
Mitton, C. R., Adair, C. E., McDougall, G. M., & Marcoux, G. (2005). Continuity of care and health care costs among persons with severe mental illness. Psychiatric Services, 56, 1070–1076.
National Quality Forum. (2012). NQF Endorses Behavioral Health Quality Measures. Retrieved from https://www.qualityforum.org/News_And_Resources/Press_Releases/2012/NQF_Endorses_Behavioral_Health_Measures.aspx.
Schmidt, S. J., & Roder, V. (2012). Psychosocial treatments in schizophrenia: Update and future directions. Minerva Psichiatrica, 53(3), 217–231.
Simon, G. E., & Unützer, J. (1999). Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatric Services, 50, 1303–1308.
Yamaki, K., Owen, R., Heller, T., & Mitchell, D. (2014). Use of preventive wellness office visits among medicaid members with disabilities: Analysis of medicaid billing data. Presentation at the American Public Health Association 142nd Annual Meeting, November 18, 2014. Retrieved from https://apha.confex.com/apha/142am/webprogram/Paper308305.html.
Yatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O’Donovan, C., et al. (2009). Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipolar Disorders, 11, 225–255.
Conflicts of interest
None.
Ethical Standards
This research was supported by a contract between the U.S. Department of Health and Human Services (DHHS), Office of the Assistant Secretary for Planning and Evaluation (ASPE) and Mathematica Policy Research (contract number HHSP23320095642WC/HHSP23337012T). Informed consent was not required for the analysis of Medicaid claims data reported in this manuscript. A Data Use Agreement between the Centers for Medicare & Medicaid Services and Mathematica Policy Research safeguarded the use of Medicaid claims data. The authors appreciate the guidance of Kirsten Beronio, John Drabek, and Richard Frank of ASPE. The views and opinions expressed in this manuscript are those of the authors and do not necessarily reflect the views, opinions, or policies of ASPE or DHHS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brown, J.D., Barrett, A., Hourihan, K. et al. State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder. Community Ment Health J 51, 523–534 (2015). https://doi.org/10.1007/s10597-015-9857-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-015-9857-5